Playlist

Turkmen Designers Showcase Heritage Collections at International Fashion Festival in Kazan

15 May. 08:15

Source

The 17th International Economic Forum "Russia – Islamic World: KazanForum 2026" hosted the "Modest Fashion Day," a premier event dedicated to the evolving global fashion industry. This platform gathered influential designers and creative professionals from Malaysia, Indonesia, Morocco, Pakistan, and Central Asian nations to explore the intersection of cultural identity and modern style.

Representing Turkmenistan, the "Miras" fashion house unveiled a collection that harmoniously integrated centuries-old folk traditions with contemporary aesthetics. The showcase featured garments adorned with intricate hand embroidery and traditional patterns, highlighting the exquisite craftsmanship of Turkmen artisans. The presentation served as a testament to the country's rich cultural legacy and its successful adaptation to the requirements of the global fashion market.

The festival’s program focused on versatile silhouettes and the principle of understated elegance for both men and women. Designers prioritized high-quality materials and authentic textile decoration techniques, such as appliqué and ethnic motifs, to create sophisticated yet functional looks. This approach facilitated a professional dialogue among industry experts regarding the development of ethical and culturally resonant design solutions.

According to forum officials and international participants, the event underscores the universal nature of modest fashion as a bridge between diverse cultures. The "Modest Fashion Day" within KazanForum continues to evolve as a vital international hub for networking and professional growth. It provides designers with significant opportunities to present their unique cultural perspectives to a global audience, fostering cross-border economic and creative collaboration.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌